Stay up-to-date on our latest news and find resources for journalists.
Apr 8, 2024
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort
Dec 29, 2023
Clover Announces Positive PhaseⅠResults for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
Dec 13, 2023
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate
Nov 7, 2023
Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil